| Product Name | Peiminine |
|---|---|
| CAS | 18059-10-4 |
| Formula | C27H43NO3 |
| MW | 429.64 |
| Appearance | 白色粉末 |
| Melting point | 212-213 °C |
| Boiling point | 567.1±50.0 °C | Condition: Press: 760 Torr |
| PKa | 14.56±0.70 | Condition: Most Acidic Temp: 25 °C |
| Product Name | Peiminine |
|---|---|
| CAS | 18059-10-4 |
| Formula | C27H43NO3 |
| MW | 429.64 |
| Appearance | 白色粉末 |
| Melting point | 212-213 °C |
| Boiling point | 567.1±50.0 °C | Condition: Press: 760 Torr |
| PKa | 14.56±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000080
中文名稱：貝母素乙
中文別名：貝母乙素；貝母寧堿；去氫貝母堿；浙貝乙素；去氫浙貝母堿；(3S,4aS,6aS,6bS,8aS,9S,9aS,12S,15aS,15bR,16aS,16bR)-3,9-二羥基-9,12,16b-三甲基二十二氫苯并[4,5]茚并[1,2-h]吡啶[1,2-b]異喹啉-5(15bH)-酮
英文名稱：Peiminine
英文別名：5α-Cevan-6-one, 3β,20-dihydroxy- (8CI);Fritillarine (6CI);Osnovanine (7CI);(3β,5α)-3,20-Dihydroxycevan-6-one;Benzo[7,8]fluoreno[2,1-b]quinolizine, cevan-6-one deriv.;Peiminine;Raddeanine;Raddeanine (Fritillaria);Verticinone;
分子式：C27H43NO3
分子量：429.64
CAS號(hào)：18059-10-4
純度：HPLC≥98%
熔點(diǎn)：212-213 °C
沸點(diǎn)：567.1±50.0 °C | Condition: Press: 760 Torr
密度：1.18±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：14.56±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請(qǐng)關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction | ||
| Source:SCI：PHARMACOLOGICAL RESEARCH | Author:Min Xu | Notes：影響因子：4.816 |
| Reference description | ||
hecogenin (1), diosgenin (2), ruscogenin (3), gitogenin (4), tigogenin (5), solasodine (6), (24S,25S)-3β, 24-di-hydroxy-5α-spirostan (7), dracaenol C (8), 25(27)-dehydroruscogenin (9), (1β, 3β, 14α, 15α, 20R, 22S, 25R)-spirost-5-ene-tetrol (10), peimine (11), peiminine (12), peimisine (13), isoverticine (14), trillin (15), polyphyllin VI (16), polyphyllin VII (17), pallidifloside D (18), prosapogenin A (19), spongipregnoloside A (20), dioscin(21), solasonine (22), solamargine (23), gracillin (24), polyphyllin I(25), timosaponin BII (26), timosaponinA-III(27), ophiopogonin D (28), protobioside (29), (22S,25S)-26-O-β-d-glucopyranosyl-22,25-epoxyfurost-5-en-3β,26-diol-3-O-α-l-rha-mnopyranosyl(1 → 2)-β-d-gluc (30), pallidifloside E (31), parispseudoside (32), methylprotodioscin (33), protodioscin (34), pseudoprotodioscin (35), YS-IX (36), pallidifloside A (37), pallidifloside H (38), digoxin (39), bisdigoxigenin (40), 7β, 14α, 21-tri-hydroxy-diosgenin (41), 12β,14α,21-tri-hydroxy-diosgenin (42), and 11β,14α-di-hydroxyldiosgenin (43) were purchase from Sichuan weikeqi biotechnology company (Sichuan province, China). Pooled human liver microsomes (HLMs, 20 mg/mL) and pooled human primary hepatocytes were purchased from Rild Research Institute for LiverDiseases (Shanghai, China). | ||
| Integrating Network Analysis and Metabolomics to Reveal Mechanism of Huaganjian Decoction in Treatment of Cholestatic Hepatic Injury. | ||
| Source:SCI：Frontiers in Pharmacology | Author:Dong Q | Notes：影響因子：5.811 |
| Reference description | ||
All 22 standard compounds used in this study (synephrine, gallic acid, chlorogenic acid, geniposide, peimine, peiminine, albiflorin, paeoniflorin, rutin, narirutin, crocin, naringin, hesperidin, neohesperidin, didymin, quercetin, benzoylpaeoniflorin, paeonol, sinensetin, nobiletin, hepta-3, and alisol B 23-acetate) were supplied by Weikeqi Biotechnology Co., Ltd (Chengdu, China), and the purity were all greater than 98%. UDCA administrated as positive control was supplied by Shanghai Aladdin Biochemical Co., Ltd. (Shanghai, China). ANIT and medical-grade soybean oil were purchased from Shanghai Aladdin Biochemical Co., Ltd. (Shanghai, China). | ||
